title: The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews.
abstract: Controversy has arisen regarding the effectiveness of neuraminidase inhibitors (NIs), especially against influenza-related complications. A literature search was performed to critically assess the evidence collected by the available systematic reviews (SRs) regarding the benefits and disadvantages of NIs (oseltamivir, zanamivir) compared to placebos in healthy and at-risk individuals of all ages for prophylaxis and treatment of seasonal influenza. A SR was done using the Cochrane Database of Systematic Reviews, Health Technology Assessment Database, Database of Abstracts of Reviews of Effects, and Medline (January 2006-July 2012). Two reviewers selected SRs based on randomized clinical trials, which were restricted to intention-to-treat results, and they assessed review (AMSTAR) and study quality indicators (GRADE). The SRs included (N = 9) were of high quality. The efficacy of NIs in prophylaxis ranged from 64% (16-85) to 92% (37-99); the absolute risk reduction ranged from 1.2% to 12.1% (GRADE moderate to low). Clinically relevant treatment benefits of NIs were small in healthy adults and children suffering from influenza-like illness (GRADE high to moderate). Oseltamivir reduced antibiotic usage in healthy adults according to one SR, but this was not confirmed by other reviews (GRADE low). Zanamivir showed a preventive effect on antibiotic usage in children (95% (77-99);GRADE moderate) and on the occurrence of bronchitis in at-risk individuals (59% (30-76);GRADE moderate). No evidence was available on the treatment benefits of NIs in elderly and at-risk groups and their effects on hospitalization and mortality. In oseltamivir trials, nausea, vomiting and diarrhea were significant side-effects. For zanamivir trials, no adverse effects have been reported. The combination of diagnostic uncertainty, the risk for virus strain resistance, possible side effects and financial cost outweigh the small benefits of oseltamivir or zanamivir for the prophylaxis and treatment of healthy individuals. No relevant benefits of these NIs on complications in at-risk individuals have been established.
authors.affiliation: Department of Primary and Interdisciplinary Care Antwerp, Centre for General Practice, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. barbara.michiels@ua.ac.be
authors.forename: Barbara
authors.initials: B
authors.lastname: Michiels
authors.forename: Karolien
authors.initials: K
authors.lastname: Van Puyenbroeck
authors.forename: Veronique
authors.initials: V
authors.lastname: Verhoeven
authors.forename: Etienne
authors.initials: E
authors.lastname: Vermeire
authors.forename: Samuel
authors.initials: S
authors.lastname: Coenen
mesh_terms: D019072:Antibiotic Prophylaxis; D006801:Humans; D007251:Influenza, Human / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control*; D009439:Neuraminidase / Q000037:antagonists & inhibitors*; D053139:Oseltamivir / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D053243:Zanamivir / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D053139:Oseltamivir; D009439:Neuraminidase; D053243:Zanamivir
references.citation: J Am Med Dir Assoc. 2005 Nov-Dec;6(6):367-74
references.pmid: 16286057
references.citation: Rev Prat. 2008 Feb 29;58(4):445-53
references.pmid: 18506987
references.citation: J Infect. 2000 Jan;40(1):42-8
references.pmid: 10762110
references.citation: BMC Med. 2009 Dec 10;7:76
references.pmid: 20003249
references.citation: Cochrane Database Syst Rev. 2010 Feb 17;(2):CD004876
references.pmid: 20166072
references.citation: Cochrane Database Syst Rev. 2008 Apr 16;(2):CD004879
references.pmid: 18425905
references.citation: BMJ. 2009 Dec 08;339:b5387
references.pmid: 19995818
references.citation: Int J Chron Obstruct Pulmon Dis. 2007;2(1):55-64
references.pmid: 18044066
references.citation: Med Lett Drugs Ther. 2012 Jan 9;54(1381):1-3
references.pmid: 22233587
references.citation: BMJ. 2009 Dec 08;339:b5106
references.pmid: 19995812
references.citation: Clin Drug Investig. 2006;26(6):329-40
references.pmid: 17163267
references.citation: Can Fam Physician. 2009 Dec;55(12):1199-201
references.pmid: 20008597
references.citation: Ther Umsch. 2007 Nov;64(11):635-41
references.pmid: 18581908
references.citation: J Infect Chemother. 2011 Jun;17(3):375-81
references.pmid: 21120678
references.citation: Infection. 2009 Jun;37(3):186-96
references.pmid: 19471854
references.citation: Arch Intern Med. 2001 Jan 22;161(2):212-7
references.pmid: 11176734
references.citation: N Engl J Med. 2000 Nov 2;343(18):1282-9
references.pmid: 11058672
references.citation: Health Technol Assess. 2009 Feb;13(11):iii, ix-xii, 1-246
references.pmid: 19215705
references.citation: Antivir Ther. 2012;17(1 Pt B):143-57
references.pmid: 22311561
references.citation: Antimicrob Agents Chemother. 2010 Jun;54(6):2575-82
references.pmid: 20368393
references.citation: Expert Opin Drug Saf. 2009 May;8(3):357-71
references.pmid: 19355841
references.citation: Health Technol Assess. 2009 Nov;13(58):1-265, iii-iv
references.pmid: 19954682
references.citation: Pathol Biol (Paris). 2010 Apr;58(2):e69-78
references.pmid: 20303677
references.citation: Clin Infect Dis. 2011 Aug 1;53(3):277-9
references.pmid: 21677258
references.citation: N Engl J Med. 2005 Sep 29;353(13):1363-73
references.pmid: 16192481
references.citation: Respirology. 2008 Mar;13 Suppl 1:S19-21
references.pmid: 18366523
references.citation: Pediatr Infect Dis J. 2001 Feb;20(2):127-33
references.pmid: 11224828
references.citation: Clin Ther. 2007 Aug;29(8):1579-90; discussion 1577-8
references.pmid: 17919541
references.citation: BMJ. 2009 Dec 08;339:b5164
references.pmid: 19995813
references.citation: Pharm Unserer Zeit. 2011 Mar;40(2):144-50
references.pmid: 21630541
references.citation: BMC Fam Pract. 2011 Feb 09;12:4
references.pmid: 21306610
references.citation: Lancet. 1998 Dec 12;352(9144):1877-81
references.pmid: 9863784
references.citation: Kansenshogaku Zasshi. 2000 Dec;74(12):1062-76
references.pmid: 11193558
references.citation: Lancet. 2006 Jan 28;367(9507):303-13
references.pmid: 16443037
references.citation: J Antimicrob Chemother. 2010 Apr;65 Suppl 2:ii11-ii24
references.pmid: 20215131
references.citation: Med Lett Drugs Ther. 2006 Oct 23;48(1246):87-8
references.pmid: 17051136
references.citation: Vaccine. 2011 Nov 15;29(49):9159-70
references.pmid: 21840359
references.citation: BMJ. 2012 Jan 17;344:d7898
references.pmid: 22252039
references.citation: J Antimicrob Chemother. 2010 Jul;65(7):1330-46
references.pmid: 20488984
references.citation: BMJ. 2009 Dec 08;339:b5248
references.pmid: 19995814
references.citation: J Antimicrob Chemother. 2011 Aug;66(8):1897-905
references.pmid: 21622674
references.citation: JAMA. 1999 Jul 7;282(1):31-5
references.pmid: 10404908
references.citation: BMC Infect Dis. 2011 May 19;11:134
references.pmid: 21592407
references.citation: Antivir Ther. 1999;4(2):61-8
references.pmid: 10682150
references.citation: J Infect Dis. 2002 Dec 1;186(11):1582-8
references.pmid: 12447733
references.citation: Semin Respir Crit Care Med. 2011 Aug;32(4):373-92
references.pmid: 21858743
references.citation: Clin Infect Dis. 2000 Mar;30(3):587-9
references.pmid: 10722450
references.citation: Cochrane Database Syst Rev. 2012 Jan 18;1:CD008965
references.pmid: 22258996
references.citation: Cochrane Database Syst Rev. 2010 Jul 07;(7):CD001269
references.pmid: 20614424
references.citation: Clin Infect Dis. 2011 Dec;53(12):1302-3; author reply 1303-4
references.pmid: 22080124
references.citation: J Infect Dis. 2000 Apr;181(4):1471-4
references.pmid: 10762579
references.citation: Cochrane Database Syst Rev. 2006 Jul 19;(3):CD001265
references.pmid: 16855962
references.citation: Cochrane Database Syst Rev. 2012 Jan 18;1:CD002744
references.pmid: 22258949
references.citation: Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008139
references.pmid: 20238363
references.citation: Clin Infect Dis. 2009 Apr 15;48(8):1003-32
references.pmid: 19281331
references.citation: Influenza Other Respir Viruses. 2007 Jan;1(1):27-34
references.pmid: 19453477
references.citation: BMJ. 2009 Aug 10;339:b3172
references.pmid: 19666987
references.citation: Chin Med J (Engl). 2003 Jan;116(1):44-8
references.pmid: 12667386
references.citation: Cochrane Database Syst Rev. 2011 Jul 06;(7):CD006207
references.pmid: 21735402
references.citation: Pediatr Infect Dis J. 2000 May;19(5):410-7
references.pmid: 10819336
references.citation: J Infect Dis. 2004 Feb 1;189(3):440-9
references.pmid: 14745701
references.citation: Antiviral Res. 2008 Apr;78(1):91-102
references.pmid: 18328578
references.citation: J Infect. 2011 Jan;62(1):14-25
references.pmid: 20950645
references.citation: Lancet Infect Dis. 2009 Sep;9(9):537-45
references.pmid: 19665930
references.citation: Cochrane Database Syst Rev. 2012 Apr 18;(4):CD002744
references.pmid: 22513907
references.citation: Antivir Ther. 2011;16(2):123-35
references.pmid: 21447860
references.citation: Adv Ther. 2011 Nov;28(11):927-59
references.pmid: 22057727
references.citation: J Postgrad Med. 2009 Jul-Sep;55(3):225-30
references.pmid: 19884755
references.citation: Pediatr Ann. 2009 Dec;38(12):667-74
references.pmid: 20000234
references.citation: Scand J Infect Dis. 2003;35(1):52-8
references.pmid: 12685885
references.citation: JAMA. 2000 Feb 23;283(8):1016-24
references.pmid: 10697061
references.citation: JAMA. 2001 Feb 14;285(6):748-54
references.pmid: 11176912
references.citation: Fam Pract. 2013 Apr;30(2):125-33
references.pmid: 22997224
references.citation: Ann Intern Med. 2009 Oct 6;151(7):464-73
references.pmid: 19652173
references.citation: Annu Rev Med. 2008;59:397-413
references.pmid: 17939760
references.citation: Clin Infect Dis. 2010 Oct 15;51(8):887-94
references.pmid: 20815736
references.citation: Cochrane Database Syst Rev. 2010 Feb 17;(2):CD001265
references.pmid: 20166059
references.citation: Drug Saf. 2008;31(12):1097-114
references.pmid: 19026027
references.citation: Dtsch Med Wochenschr. 2008 Jun;133(23):1259-64
references.pmid: 18509804
references.citation: Int J Risk Saf Med. 2011;23(2):65-71
references.pmid: 21673413
references.citation: Int J Chron Obstruct Pulmon Dis. 2007;2(1):5-10
references.pmid: 18044060
references.citation: Pharmacotherapy. 2006 Jan;26(1):95-103
references.pmid: 16506351
references.citation: Zhonghua Jie He He Hu Xi Za Zhi. 2004 Jul;27(7):455-9
references.pmid: 15312558
references.citation: Internist (Berl). 2006 Dec;47(12):1245-50
references.pmid: 17009040
references.citation: Med Lett Drugs Ther. 2009 Nov 16;51(1325):89-92
references.pmid: 20220738
references.citation: N Engl J Med. 1999 Oct 28;341(18):1336-43
references.pmid: 10536125
references.citation: Zhonghua Yi Xue Za Zhi. 2004 Dec 17;84(24):2132-6
references.pmid: 15730636
references.citation: Expert Opin Drug Metab Toxicol. 2007 Oct;3(5):755-67
references.pmid: 17916060
references.citation: Semin Respir Crit Care Med. 2007 Apr;28(2):144-58
references.pmid: 17458769
references.citation: Clin Pharmacokinet. 1999;36 Suppl 1:51-8
references.pmid: 10429840
references.citation: Arch Intern Med. 2003 Jul 28;163(14):1667-72
references.pmid: 12885681
references.citation: Lancet. 2000 May 27;355(9218):1845-50
references.pmid: 10866439
references.citation: Expert Opin Pharmacother. 2011 Jul;12(10):1523-49
references.pmid: 21438743
references.citation: Pharm Unserer Zeit. 2011 Mar;40(2):151-4
references.pmid: 21630542
references.citation: Expert Opin Drug Saf. 2006 Sep;5(5):603-8
references.pmid: 16907649
references.citation: J Clin Epidemiol. 2011 Apr;64(4):383-94
references.pmid: 21195583
references.citation: J Am Geriatr Soc. 2001 Aug;49(8):1025-31
references.pmid: 11555062
references.citation: Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002744
references.pmid: 17253479
references.citation: J Clin Epidemiol. 2009 Oct;62(10):1013-20
references.pmid: 19230606
references.citation: Pediatr Infect Dis J. 2005 Mar;24(3):225-32
references.pmid: 15750458
references.citation: N Engl J Med. 1997 Sep 25;337(13):874-80
references.pmid: 9302301